美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
60505-4130-5	60505-4130	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE	OXCARBAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20240903	N/A	ANDA	ANDA213369	Apotex Corp.	OXCARBAZEPINE	600 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4130-5)
60505-4130-7	60505-4130	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE	OXCARBAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20240903	N/A	ANDA	ANDA213369	Apotex Corp.	OXCARBAZEPINE	600 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4130-7)
60505-4128-5	60505-4128	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE	OXCARBAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20240903	N/A	ANDA	ANDA213369	Apotex Corp.	OXCARBAZEPINE	150 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4128-5)
60505-4128-7	60505-4128	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE	OXCARBAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20240903	N/A	ANDA	ANDA213369	Apotex Corp.	OXCARBAZEPINE	150 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4128-7)
60505-4129-5	60505-4129	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE	OXCARBAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20240903	N/A	ANDA	ANDA213369	Apotex Corp.	OXCARBAZEPINE	300 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4129-5)
60505-4129-7	60505-4129	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE	OXCARBAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20240903	N/A	ANDA	ANDA213369	Apotex Corp.	OXCARBAZEPINE	300 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4129-7)